Sort
23,748 grants matching “melanoma”
Prevention of Post-Surgical Lymphedema using Tissue Nanotransfection Technology
$383,574Aladdin Hasan Hassanein · Indiana University Indianapolis · R21 · FY2023 · AR
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation
$383,572Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
$383,563Brendan D. Manning · Harvard School Of Public Health · R01 · FY2015 · CA
MECHANISMS OF UV-INDUCED MELANOMA INITIATION. NEW AWARD.
$383,448University Of Utah · · FY2020 · Defense Health Agency
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$383,419Aaron Michael Ring · Yale University · P50 · FY2023 · CA
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma
$383,417Qin Yan · Yale University · P50 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP STUDIES
$383,406Case Western Reserve University · U10 · FY2003 · CA
UT MD ANDERSON CCOP RESEARCH BASE
$383,357University Of Texas Md Anderson Can Ctr · U10 · FY2000 · CA
The regulation of melanocyte stem cells by Wnt signaling
$383,350Mayumi Ito · New York University School Of Medicine · R01 · FY2025 · AR
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
$383,350Ryan Bruce Corcoran · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$383,327Benjamin Izar · Columbia University Health Sciences · R37 · FY2024 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$383,285Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$383,223Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2024 · CA
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.
$383,159Cherie-Ann O Nathan · Louisiana State Univ Hsc Shreveport · R01 · FY2022 · CA
The Inflammasome as a novel mediator and therapeutic target of GI syndrome
$383,156Richard A Flavell · Yale University · R01 · FY2021 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2020 · CA
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and Metastasis
$383,156Narendra Wajapeyee · Yale University · R01 · FY2017 · CA
The Inflammasome as a novel mediator and therapeutic target of GI syndrome
$383,156Richard A Flavell · Yale University · R01 · FY2020 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2021 · CA
The Inflammasome as a novel mediator and therapeutic target of GI syndrome
$383,156Richard A Flavell · Yale University · R01 · FY2018 · CA
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
$383,156Narendra Wajapeyee · Yale University · R01 · FY2018 · CA
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and Metastasis
$383,156Narendra Wajapeyee · Yale University · R01 · FY2018 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2017 · CA
Inherent tropism and/or immune modulation in melanoma brain metastasis
$383,156Lucia Beatrice Jilaveanu · Yale University · R01 · FY2018 · CA
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
$383,156Narendra Wajapeyee · Yale University · R01 · FY2017 · CA